Antibiotics
Accelr8 Announces Industry Agreement for Technology Evaluation Project
Published in Drug Week, July 2nd, 2010
Accelr8 Technology Corporation (NYSE Amex: AXK) announced that it signed a technology evaluation agreement for its BACcel™ rapid diagnostic system with a global diagnostics company. The short-term agreement includes an option for a license to complete product development, obtain regulatory approvals, and produce and market innovative diagnostic products based on the technology in global markets. The agreement calls for an initial payment plus scheduled payments of additional funds until completion of data evaluation.
The project incorporates analysis of data being collected in pre-clinical and pilot studies already initiated at the Denver Health Medical Center,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2010-07-02)
More Articles from Drug Week
- Adenosine Therapy
Acupuncture's molecular effects pinned down - Analgesics
Colombian Trafficker with Links to Mexican and Colombian Cartels Extradited from Mexico to the U.S. - Cancer Therapy
Data on cancer therapy discussed by researchers at Brussels Free University - Drug Development
Data on drug development published by L.Q. Cong and colleagues - Propylamines
Data on propylamines reported by researchers at Charite University - Risperidone Therapy
Data on risperidone therapy described by researchers at Ludwig-Maximilians University - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
